This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 1982 Sep 30;695(1):49-67.

doi: 10.1016/0304-419x(82)90006-3.

Implications for clinical application of new developments in interferon research

J Taylor-Papadimitriou, F R Balkwill

PMID: 6182911
DOI: 10.1016/0304-419x(82)90006-3

Comparative Study

Implications for clinical application of new developments in interferon research

J Taylor-Papadimitriou et al. Biochim Biophys Acta. 1982.

. 1982 Sep 30;695(1):49-67.

doi: 10.1016/0304-419x(82)90006-3.

Authors

J Taylor-Papadimitriou, F R Balkwill

PMID: 6182911
DOI: 10.1016/0304-419x(82)90006-3

No abstract available

PubMed Disclaimer

Similar articles

[Problems of clinical application of interferon].
Shishido A, Kohno S. Shishido A, et al. Nihon Rinsho. 1977 Sep 10;35(9):2832-7. Nihon Rinsho. 1977. PMID: 200779 Review. Japanese. No abstract available.
Prospects for the clinical use of exogenous interferon.
Cantell K. Cantell K. Med Biol. 1977 Apr;55(2):69-73. Med Biol. 1977. PMID: 194114 Review.
[Therapeutic use of interferon: current trends and prospects].
Laghi V, Toccaceli F. Laghi V, et al. Medicina (Firenze). 1990 Apr-Jun;10(2):201-11. Medicina (Firenze). 1990. PMID: 1703261 Review. Italian. No abstract available.
Clinical trials with exogenous interferon: summary of a meeting.
Dunnick JK, Galasso GJ. Dunnick JK, et al. J Infect Dis. 1979 Jan;139(1):109-23. doi: 10.1093/infdis/139.1.109. J Infect Dis. 1979. PMID: 220327 Review. No abstract available.
Interferons in cancer therapy: a reappraisal.
Balkwill FR, Smyth JF. Balkwill FR, et al. Lancet. 1987 Aug 8;2(8554):317-9. doi: 10.1016/s0140-6736(87)90901-9. Lancet. 1987. PMID: 2441217 No abstract available.

See all similar articles

Cited by

Interferon therapy and immunity.
Woodrow DF. Woodrow DF. J R Soc Med. 1983 Mar;76(3):230-3. doi: 10.1177/014107688307600319. J R Soc Med. 1983. PMID: 6187920 Free PMC article. No abstract available.
Positive interactions between human interferon and cepharanthin against human cancer cells in vitro and in vivo.
Ono M, Tanaka N, Orita K. Ono M, et al. Cancer Chemother Pharmacol. 1994;35(1):10-6. doi: 10.1007/BF00686278. Cancer Chemother Pharmacol. 1994. PMID: 7527303
Interferon-gamma and cytotoxic agents studied in combination using a soft agarose human tumor clonogenic assay.
Saito T, Berens ME, Welander CE. Saito T, et al. Cancer Chemother Pharmacol. 1987;19(3):233-9. doi: 10.1007/BF00252978. Cancer Chemother Pharmacol. 1987. PMID: 3107848
Cyclic AMP mediates the direct antiproliferative action of mismatched double-stranded RNA.
Hubbell HR, Boyer JE, Roane P, Burch RM. Hubbell HR, et al. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):906-10. doi: 10.1073/pnas.88.3.906. Proc Natl Acad Sci U S A. 1991. PMID: 1846967 Free PMC article.
Interferon-beta can induce the production of plasminogen activator by cultured human cancer cells.
Karai M, Namba M. Karai M, et al. Experientia. 1987 Apr 15;43(4):435-7. doi: 10.1007/BF01940443. Experientia. 1987. PMID: 3569495

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science